Skip to content

Effects of transcutaneous electrical acupoint stimulation and dezocine on treatment and prevention of sufentanil-cough incidence under general anesthesia

Effects of transcutaneous electrical acupoint stimulation pretreament on treatment and prevention of sufentanil-cough incidence under general anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000039787
Enrollment
Unknown
Registered
2020-11-10
Start date
2020-11-16
Completion date
Unknown
Last updated
2021-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

patients under general anesthesia

Interventions

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: ASA I-II, aged 18-60 years, weighing 45-90kg, BMI 15-30kg / m2, undergoing surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: (1) There are surgical incision or scar in meridian where Tiantu point is located; (2) The infection of upper respiratory tract and taking ACEI within 2 weeks due to asthma history; (3) The patients with skin infection at acupoints; (4) The patients with difficult airway; (5) The patients who have participated in other clinical trials in recent four weeks; (6) The patients with pacemaker application; (7) The pregnant women and The patients with positive urine pregnancy test; (8) The patients with preoperative pain, using analgesics, opioid addicts and addicts; (9) The patients with severe central nervous system diseases and serious mental diseases; (10) The patients with liver and kidney dysfunction (ALT,AST,BUN,Cr exceeding 1.5 times of normal values); (11) The patients with alcohol history; (12) Severe complications such as massive hemorrhage occurred during operation or within 24 hours after operation; (13) The patients who were considered unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
cough;

Secondary

MeasureTime frame
heart rate;Blood Pressure;SPO2;

Countries

China

Contacts

Public ContactZhifeng Lyu

The First Affiliated Hospital of Henan University of Chinese Medicine

mazui1846@126.com+86 0371-66245047

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026